The epidemiology of lead toxicity in adults: Measuring dose and consideration of other methodologic issues

Environmental Health Perspectives

Volumn 115, Issue 3, 2007, Pages 455-462

  Hu, Howard ^a,b,c   Shih, Regina ^d   Rothenberg, Stephen ^e,f   Schwartz, Brian S ^g,h  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e DEPARTAMENTO DE FÍSICA APLICADA   (Mexico)

^f INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^g The Johns Hopkins University   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adults; Biomarkers; Epidemiologic methods; Epidemiology; Lead; Toxicity

Indexed keywords

LEAD;

ADULT; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENVIRONMENTAL EXPOSURE; ETHNICITY; HUMAN; INCIDENCE; LABORATORY TEST; LEAD BLOOD LEVEL; LEAD POISONING; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; STANDARDIZATION; SYSTEMATIC REVIEW; TOXICOKINETICS; TOXIN ANALYSIS; URINARY EXCRETION; VALIDITY; X RAY FLUORESCENCE;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; ENVIRONMENTAL EXPOSURE; HUMANS; LEAD; LEAD POISONING;

EID: 34147165170     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9783     Document Type: Review

References (109)

1. Agency for Toxic Substances and Disease Registry. 1999. Toxicological Profile for Lead. Update, 1999, Atlanta, GA:Agency for Toxic Substances and Disease Registry.
2. Annest JL, Pirkle JL, Makuc D, Neese JW, Bayse DO, Kovar MG. 1983. Chronological trend in blood lead levels between 1976 and 1980. N Engl J Med 308(23):1373-1377.
3. Armstrong R, Chettle DR, Scott MC, Somervaille LJ, Pendlington M. 1992. Repeated measurements of tibia lead concentrations by in vivo x ray fluorescence in occupational exposure. Br J Ind Med 49(1):14-16.
4. Aro A, Amarasiriwardena C, Lee ML, Kim R, Hu H 2000, Validation of K x-ray fluorescence bone lead measurements by inductively coupled plasma mass spectrometry in cadaver legs. Med Phys 27(1):119-123.
5. Aro AC, Todd AC, Amarasiriwardena C, Hu H. 1994. Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol 39(12): 2263-2271.
6. Balbus-Kornfeld JM, Stewart W, Bolla KI, Schwartz BS. 1995. Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: an epidemiological review Occup Environ Med 52(1):2-12.
7. Banks EC, Ferretti LE, Shucard DW. 1997. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology 18(1):237-281.
8. Barltrop D, Smith A. 1972. Lead binding to human haemoglobin. Experientia 28(1):76-77
9. Barry PS, Mossman DB 1970. Lead concentrations in human tissues. Br J Ind Med 27(4):339-351.
10. Beilin LJ, Puddey IB 2006. Alcohol and hypertension: an update. Hypertension 47(6):1035-1038.
11. Bergdahl A, Grubb A, Schulz A, Desnick RJ, Wetmur JG, Sassa S, et al. 1997. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 81(4):153-158.
12. Cake KM, Bowins RJ, Vaillancourt C, Gordon CL, McNutt RH, Laporte R, et al 1996. Partition of circulating lead between serum and red cells is different for internal and external sources of lead Am J Ind Med 29(5):440-445.
13. Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. 2003. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348(16):1517-1526.
14. Carmelli D, Swan GE, Reed T, Schellenberg GD, Christian JC. 1999. The effect of apolipoprotein E ε4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology 18(3):125-133.
15. Cervilla JA, Prince M, Joels S, Lovestone S, Mann A. 2000. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 177:66-71.
16. 109Cd. Environ Health Perspect 91:49-55.
17. Church HJ, Day JP, Braithwaite RA, Brown SS. 1993. Binding of lead to a metallothionein-like protein in human erythrocytes. J Inorg Biocham 49(1):55-68.
18. Crawford FC, Freeman MJ, Schinka JA, Morris MD, Abdullah LI, Richards D, et al. 2001. Association between Alzheimer's disease and a functional polymorphism in the myeloperoxidase gene. Exp Neurol 167(2):456-459.
19. Dorsey CD, Lee BK, Bolla KI, Weaver VM, Lee SS, Lee GS, et al. 2006. Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores. J Occup Environ Med 48(5):489-496.
20. Elias PK, Elias MF, D'Agostino RB, Silbershatz H, Wolf PA. 1999. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol 150(6):580-589.
21. Elmarsafawy SF, Tsaih SW, Korrick S, Dickey JH, Sparrow D, Aro A, et al. 2002. Occupational determinants of bone and blood lead levels in middle aged and elderly men from the general community: the Normative Aging Study. Am J Ind Med 42(1):38-49.
22. Elreedy S, Krieger N, Ryan PB, Sparrow O, Weiss ST, Hu H. 1999. Relations between individual and neighborhood-based measures of socioeconomic position and bone lead concentrations among community-exposed men: the Normative Aging Study. Am J Epidemiol 150(2):129-141.
23. Elwood PC, Gallacher JE, Hopkinson CA, Pickering J, Rabbitt P, Stollery B, et al. 1999. Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort. J Epidemiol Commun Health 53(1):9-14.
24. Erkkila J, Armstrong R, Riihimaki V, Chettle DR, Paakkari A, Scott M, et al. 1992. In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogamous exposure. Br J Ind Med 49(9):631-644.
25. Gerhardsson L, Chettle DR, Englyst V, Nordberg GF, Nyhlin H, Scott MC, et al. 1992. Kidney effects in long term exposed lead smelter workers. Br J Ind Med 49(3):186-192.
26. Ghorbe F, Boujelbene M, Makni-Ayadi F, Guermazi F, Kammoun A, Murat J, et al. 2001. Effect of chronic lead exposure on kidney function in male and female rats: determination of a lead exposure biomarker. Arch Physiol Biochem 109(5):457-463.
27. Goldman RH, White R, Kales SN, Hu H. 1994. Lead poisoning from mobilization of bone stores during thyrotoxicosis. Am J Ind Med 25(3):417-424.
28. Goldstein GW, Ar D. 1983. Lead activates calmodulin sensitive processes. Life Sci 33(10):1001-1006.
29. Goodman M, LaVerda N, Clarke C, Foster ED, Iannuzzi J, Mandel J. 2002, Neurobehavioural testing in workers occupationally exposed to lead: systematic review and meta-analysis of publications. Occup Environ Med 59(4):217-223.
30. Hall EJ. 1988. Radiation protection. In: Radiology for the Radiologist. 3rd ed. Philadelphia:Lippincott.
31. Harkins DK, Susten AS. 2003. Hair analysis: exploring the state of the science. Environ Health Perspect 111:576-578.
32. Hendrie HC, Gao S, Hall KS, Hui SL, Unverzagt FW. 1996. The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older black Americans. J Am Geriatr Soc 44(10):1158-1165.
33. Hertz-Picciotto I, Croft J. 1993. Review of the relation between blood lead and blood pressure. Epidemiol Rev 15(2):352-373.
34. Hoppin JA, Aro AC, Williams PL, Hu H, Ryan PB. 1995. Validation of K-XRF bone lead measurement in young adults. Environ Health Perspect 103:78-83.
35. Hu H. 1998. Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. Environ Health Perspect 106(suppl 4):961-967.
36. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, et al. 1996a. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 275(15):1171-1176.
37. Hu H, Milder FL, Burger DE. 1989. X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead. Environ Res 49(2):295-317.
38. Hu H, Milder FL, Burger DE. 1991a. The use of K X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens and measurement uncertainty. Environ Health Perspect 94:107-110.
39. Hu H, Payton M, Korrick S, Aro A, Sparrow D, Weiss ST, et al. 1996b. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol 144(8):749-759.
40. Hu H, Pepper L, Goldman R. 1991b. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone. Am J Ind Med 20(6):723-735.
41. Hu H, Rabinowitz M, Smith D, 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106:1-8.
42. Hu H, Tellez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, et al. 2006. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect 114:1730-1735.
43. Hu H, Tosteson T, Aufderheide AC, Wittmers L, Burger DE, Milder FL, et al. 1990. Distribution of lead in human bone: I. Atomic absorption measurements. Basic Life Sci 55:267-274.
44. Kern M, Wisniewski M, Cabell L, Audesirk G. 2000. Inorganic lead and calcium interact positively in activation of calmodulin. Neurotoxicology 21(3):353-363.
45. Kim R, Aro A, Rotnitzky A, Amarasiriwardena C, Hu H. 1995. K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol 40(9):1475-1485.
46. Kim R, Landrigan C, Mossmann P, Sparrow D, Hu H. 1997. Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol 146(7):586-591
47. Korrick SA, Schwartz J, Tsaih SW, Hunter DJ, Aro A, Rosner B, et al. 2002. Correlates of bone and blood lead levels among middle-aged and elderly women. Am J Epidemiol 156(4): 335-343.
48. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. 2001. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 158(6):848-856.
49. Landrigan PJ, Todd AC, 1994. Direct measurement of lead in bone. A promising biomarker. JAMA 271(3):239-240.
50. Lasley SM, Gilbert ME. 2002. Rat hippocampal glutomate and GABA release exhibit biphasic effects as a function of chronic lead exposure level. Toxicol Sci 66(1):139-147.
51. LaVeist TA. 1994. Beyond dummy variables and sample selection: what health services researchers ought to know about race as a variable, Health Serv Res 29(1):1-16.
52. Lee BK, Schwartz BS, Stewart W, Ahn KD. 1995, Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites. Occup Environ Med 52(1): 13-19.
53. Lee MG, Chun OK, Song WO. 2005. Determinants of the blood lead level of US women at reproductive age. J Am Coll Nutr 24(1):1-9.
54. Lin C, Kim R, Tsaih SW, Sparrow D, Hu H. 2004, Determinants of bone and blood lead levels among minorities living in the Boston area. Environ Health Perspect 112:1147-1151.
55. Lindgren KN, Masten VL, Ford DP, Bleecker ML. 1996. Relation of cumulative exposure to inorganic lead and neuropsychological test performance, Occup Environ Med 53(7):472-477.
56. Martin D, Glass TA, Bandeen-Roche K, Todd AC, Shi W, Schwartz BS. 2006. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol 163(5):467-478.
57. McNeill FE, Stokes L, Brito JA, Chettle DR, Kaye WE. 2000. 109Cd K x ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood. Occup Environ Med 57(7):465-471.
58. Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB, et al. 2003. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 289(12):1523-1532.
59. Navas-Acien A, Guallar E, Sillbergeld EK, Rothenberg SJ. 2007. Lead exposure and cardiovascular disease - a systematic review. Environ Health Perspect 115:472-482.
60. Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, et al. 1979. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 300(13):689-695.
61. Needleman HL, McFarland C, Ness RB, Fienberg SE, Tobin MJ. 2002. Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol 24(6):711-717.
62. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. 1996. Bone lead levels and delinquent behavior. JAMA 275(5):363-369.
63. Nuyts GD, Elseviers MM, Do Broe ME. 1993. Healthy worker effect in a cross-sectional study of lead workers. J Occup Med 35(4):387-391.
64. O'Flaherty EJ. 1993. Physiologically based models for bone-seeking elements. IV. Kinetics of lead disposition in humans. Toxicol Appl Pharmacol 118(1):16-29.
65. Omae K, Sakurai H, Higashi T, Mato T, Ichikawa M, Sasaki N. 1990. No adverse effects of lead on renal function in lead-exposed workers. Ind Health 28(2):77-83.
66. Orth SR. 2004. Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. J Am Soc Nephrol 15(suppl 1):S58-S63.
67. Parkinson DK, Ryan C, Bromet EJ, Connell MM. 1986. A psychiatric epidemiologic study of occupational lead exposure. Am J Epidemiol 123(2):261-269.
68. Pirkle JL, Brody DJ, Gunter EW, Kramer FA, Paschal DC, Flegal KM, et al. 1994. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 272(4):284-291.
69. Pirkle JL, Kaufmann RB, Brody DJ, Hickman T, Gunter EW, Paschal DC. 1998. Exposure of the U.S. population to lead, 1991-1994 Environ Health Perspect 106:745-750.
70. Pocock SJ, Smith M, Baghurst P. 1994. Environmental lead and children's intelligence: a systematic review of the epidemiological evidence. BMJ 309(6963):1189-1197.
71. Rabinowitz MB. 1991. Toxicokinetics of bone lead. Environ Health Perspect 91:33-37
72. Rabinowitz ME, Wetherill GW, Kopple JD. 1973. Lead metabolism in the normal human: stable isotope studies. Science 182(113):725-727.
73. Rabinowitz MB, Wetherill GW, Kopple JD. 1976. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 58(2):260-270.
74. Rabinowitz ME, Wetherill GW, Kopple JD. 1977. Magnitude of lead intake from respiration by normal man. J Lab Clin Med 90(2):238-248.
75. Rhodes D, Spiro A, III, Aro A, Hu H. 2003. Relationship of bone and blood lead levels to psychiatric symptoms: the Normative Aging Study. J Occup Environ Med 45(11):1144-1151.
76. Robins JM, Hernan MA, Brumback B. 2000. Marginal structural models and causal inference in epidemiology. Epidemiology 11(5):550-560
77. Roels H, Konings J, Green S, Bradley D, Chettle D, Lauwerys R. 1995. Time-integrated blood lead concentration is a valid surrogate for estimating the cumulative lead dose assessed by tibial lead measurement. Environ Res 69(2):75-82.
78. Roels H, Lauwerys R, Konings J, Buchet JP, Bernard A, Green S, et al. 1994. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med 51(8):505-512.
79. Rosen JF, Slatkin DN. 1993. A commentary on in vivo lead X-ray fluorescence with reference to the 1992 workshop. Neurotoxicology 14(4):537-540.
80. Schafer JH, Glass TA, Bressler J, Todd AC, Schwartz BS. 2005. Blood lead is a predictor of homocysteine levels in a population-based study of older adults Environ Health Perspect 113:31-35
81. Schinka JA, Belanger H, Mortimer JA, Borenstein Graves A. 2003, Effects of the use of alcohol and cigarettes on cognition in elderly African American adults. J Int Neuropsychol Soc 9(5):690-697.
82. Schinka JA, Vanderploeg RD, Rogish M, Graves AB, Mortimer JA, Ordoric PI. 2002. Effects of the use of alcohol and cigarettes on cognition in elderly adults. J Int Neuropsychol Soc 8(6):811-818.
83. Schlenker TL, Fritz CJ, Mark D, Layde M, Linke G, Murphy A, et al. 1994. Screening for pediatric lead poisoning. Comparability of simultaneously drawn capillary and various blood samples. JAMA 271(17):1346-1348.
84. Schroeder HA, Tipton IH. 1968. The human body burden of lead. Arch Environ Health 17(6):965-978.
85. Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, et al. 2005. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology 16(1):106-113.
86. Schwartz BS, Lee BK, Lee GS, Stewart WF, Lee SS, Hwang KY, et al. 2001. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 153(5):453-464.
87. Schwartz BS, Lee BK, Stewart W, Ahn KD, Springer K, Kelsey K. 1995. Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 142(7):738-745.
88. Schwartz BS, Stewart WF, Kelsey KT, Simon D, Park S, Links JM, et al. 2000. Associations of tibial lead levels with Bsml polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect 108:190-203.
89. Seidel S, Kreutzer R, Smith D, McNeal S, Gilliss D. 2001. Assessment of commercial laboratories performing hair mineral analysis. Jama 285(1):67-72.
90. Sharp DS, Becker CE, Smith AH. 1987, Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol 2(3):210-232.
91. Shih RA, Glass TA, Bandeen-Roche K, Carlson MC, Bolla KI, Todd AC, et al. 2006. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology 67(9):1556-1562.
92. Shih RA, Hu H, Weisskopf MG, Schwartz BS. 2007. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 115:483-492.
93. Silbergeld EK, Schwartz J, Mahaffey K. 1988. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 47(1):79-94.
94. Simons TJ. 1984. Active transport of lead by human red blood cells. FEBS Lett 172(2):250-254.
95. Simons TJ. 1988. Active transport of lead by the calcium pump in human red cell ghosts. J Physiol 405:105-113.
96. Smith D, Hernandez-Avila M, Tellez-Rojo MM, Mercado A, Hu H. 2002. The relationship between lead in plasma and whole blood in women. Environ Health Perspect 110:263-268.
97. Sokas RK, Atleson J, Keogh JP. 1988. Shortened forms of provocative lead chelation. J Occup Med 30(5):420-424.
98. Somervaille LJ, Chettle DR, Scott MC. 1985. In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol 30(9):929-943.
99. Somervaille LJ, Chettle OR, Scott MC, Tennant DR, McKiernan MJ, Skilbeck A, et al. 1988. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med 45(3):174-181.
100. Stayner L, Steenland K, Dosemeci M, Hertz-Picciotto I. 2003. Attenuation of exposure-response curves in occupational cohort studies at high exposure levels. Scand J Work Environ Health 29(4):317-324.
101. Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. 1999. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology 52(8):1610-1617.
102. Todd AC, McNeill FE, Fowler BA, 1992a. In vivo X-ray fluorescence of lead in bone. Environ Res 59(2):326-335.
103. 109Cd sources: radiation dosimetry studies. Environ Res 57(2):117-132.
104. Tsaih SW, Korrick S, Schwartz J, Lee ML, Amarasiriwardena C, Aro A, et al. 2001. Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study. Environ Health Perspect 109:995-999.
105. Wang VS, Lee MT, Chico JY, Guu CF, Wu CC, Wu TN, et al. 2002. Relationship between blood lead levels and renal function in lead battery workers. Int Arch Occup Environ Health 75(8): 569-575.
106. Weaver VM, Lee BK, Todd AC, Jaar BG, Ahn KD, Wen J, et al. 2005. Associations of patella lead and other lead biomarkers with renal function in lead workers. J Occup Environ Med 47(3):235-243.
107. Webber CE, Chettle DR, Bowins RJ, Beaumont LF, Gordon CL, Song X, et al. 1995. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect 103:1150-1153.
108. White PD, Van Leeuwen P, Davis BD, Maddaloni M, Hogan KA, Marcus AH, et al. 1998. The conceptual structure of the integrated exposure uptake biokinetic model for lead in children. Environ Health Perspect 106(suppl 6):1513-1530.
109. Wittmers LE Jr, Aufderheide AC, Wallgren J, Rapp G Jr, Alich A. 1988. Lead in bone. IV. Distribution of lead in the human skeleton. Arch Environ Health 43(6):381-391.